Absci Corp (ABSI) - P/E Multiple

Corporate emblem and logo of Absci Corp (ABSI)

Absci (ABSI) combines generative AI-driven antibody development and new contracts with pharma behemoths with the use of cloud computing to optimize biodata transmission. The price action of the asset with the -15.20 indicator clearly demonstrates the current stage of development. Meanwhile, the business relies exclusively on external investments, as the partnership launch phase has not yet generated stable profits from finished products.

ABSI - Absci Corporation Price to Earnings Ratio over the range 07/04/2022 - 11/10/2026

Comprehensive metric breakdowns and analytics for Absci Corp. (ABSI)

- current price and projected stock value:
Share Price absci.com|ABSI - Analyst Consensus Forecast
- market capitalization indicators:
Market Capitalization Absci Corporation|ABSI - Enterprise Value
- company book value details:
Net Assets per Single Share Absci|ABSI - Company Book Value|Market Capitalization to Book Value absci.com|ABSI - Company Total Assets
- debt and solvency information:
Total Debt to Equity Ratio Absci|ABSI - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Absci Bio|ABSI - Company Aggregate Debts|Debts to Book Capitalization Absci Corporation|ABSI - Company Long-Term Debts|Company Short-Term Debt Absci|Interim Coverage Ratio absci.com
- earnings and market ratios statistics:
ABSI - Net Profit|Company Profit Forecast Absci|ABSI - P/E Multiple|Market Cap to Projected Earnings Absci Corp|ABSI - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Absci Corporation|ABSI - Operating profit before deduction of amortization|Earnings per share for the trailing year Absci|ABSI - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months absci.com|ABSI - Earnings growth in current year|Expected net earnings per share growth next year Absci
Summary company analysis:ABSI, absci.com
Signature product of Absci

Absci monetizes its AI platform through large-scale B2B contracts for accelerated protein synthesis. The current P/E valuation reflects a market premium for this technological potential, weighing total market capitalization against actual earnings. This trend captures the balance between investor expectations and real financial results across reporting periods. High values here signal expensive capital and inflated bets on future growth.

Key competitors

Price to Earnings Multiple VEEV (veeva.com)|P/E Multiple DOCS|P/E Multiple HealthEquity Inc (HQY)|P/E Multiple WAY (Waystar Inc.)|CorVel Corp. - Price to Earnings Ratio|PRVA - Price to Earnings Ratio|Business Payback Period huronconsultinggroup.com HURN|CERT: P/E Multiple|Price to Earnings Ratio Omnicell Inc|GDRX (GoodRx Corp) - P/E Multiple|Schrodinger Corp (SDGR) - Business Payback Period|P/E Multiple PHR|P/E Multiple omadahealth.com (OMDA)|P/E Multiple EVH (Evolent Health)|HealthStream Inc - Price to Earnings Ratio|DH - Price to Earnings Ratio|Business Payback Period Consensus Corp CCSI|AGL: P/E Multiple|SY - Business Payback Period|NRC (National Research Corporation) - P/E Multiple|Spok Holdings Inc (SPOK) - Business Payback Period|Price to Earnings Ratio OPRX (OptimizeRx Corp.)|Market Price to Net Income Ratio TBRG|Simulations Plus, Inc. - Price to Earnings Ratio|Company Value to Net Income SOPH|HCAT - Price to Earnings Ratio|CareCloud, Inc. (CCLD) - Price to Earnings Ratio|RSSS: P/E Multiple|Market Cap to Earnings DLH Holdings (DLHC)|ONMD (OneMedNet Corp) - P/E Multiple|Price to Earnings Multiple SCNX (scienture.com)|P/E Multiple HCTI|P/E Multiple ispecimen.com (ISPC)|P/E Multiple BFRG (Bullfrog AI)|SCWorx Inc - Price to Earnings Ratio|MSPR - Price to Earnings Ratio|Business Payback Period iCoreConnect Inc. ICCT|MEDS: P/E Multiple|Price to Earnings Ratio Orgenesis Inc|RCM (R1 RCM, Inc.) - P/E Multiple|Sharecare Inc (SHCR) - Business Payback Period|P/E Multiple STRM|P/E Multiple syrahealth.com (SYRA)|P/E Multiple AMEH (Apollo Medical Holdings, Inc.)|Model N Inc - Price to Earnings Ratio|NXGN - Price to Earnings Ratio